INDIVIOR PHARMACEUTICALS INC Call options
Reported by EQUITEC PROPRIETARY MARKETS LLC
First reported at 30,000 underlying shares controlled this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2026-09-30 | 1075500 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Underlying shares | Change | % of reported 13F | Reported notional value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | New | 30,000 | +30,000 (0.0%) | 0.27% | $1,075,500 | 2026-11-04 |
Who else reported the position
6 managers reported INDIVIOR PHARMACEUTICALS INC for Q3 2026.
| Manager | Activity | Underlying shares | Change | % of reported 13F | Reported notional value | Tenure |
|---|---|---|---|---|---|---|
| JANE STREET GROUP LLC | Reduced | 511,400 | -845,300 | < 0.01% | $18,333,690 | 3 qtrs |
| SUSQUEHANNA INTERNATIONAL GROUP LLP | Reduced | 232,700 | -674,600 | < 0.01% | $8,342,295 | 3 qtrs |
| Caption Management LLC | New | 100,000 | +100,000 | 0.01% | $3,585,000 | 3 qtrs |
| EQUITEC PROPRIETARY MARKETS LLC This report | New | 30,000 | +30,000 | 0.27% | $1,075,500 | 1 qtr |
| CITADEL ADVISORS LLC | Reduced | 24,400 | -93,100 | < 0.01% | $874,740 | 3 qtrs |
| UBS Group AG | Reduced | 18,700 | -1,300 | < 0.01% | $670,395 | 2 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 04, 2026
- Filing type
- 13F-HR
- Position type
- Call options
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.